Research Associate 2
Natera
Summary
As part of our Boulder R&D team, you'll work hands-on with scientists developing ultrasensitive, cell-free DNA technology designed to detect smaller tumors earlier and enable more personalized treatment for patients with cancer. You'll run experiments across the NGS workflow, from gDNA isolation and library prep to hybrid capture and sequencing, using automated liquid handlers and instruments like the TapeStation and Qubit.
Job description
About the Role
As part of our Boulder R&D team, you'll work hands-on with scientists developing ultrasensitive, cell-free DNA technology designed to detect smaller tumors earlier and enable more personalized treatment for patients with cancer. You'll run experiments across the NGS workflow, from gDNA isolation and library prep to hybrid capture and sequencing, using automated liquid handlers and instruments like the TapeStation and Qubit.
Primary Responsibilities
- Independently execute simple experiments and perform basic troubleshooting
- Produce competent, reproducible results to a high technical standard
- Maintain accurate and well-organized laboratory records, worksheets and notebooks
- Summarize data in spreadsheets, graphs and presentations
- Write standard operating procedures (SOP) and other lab-related documents as needed
- Maintain equipment and instruments in good operating condition, recognize any malfunctions and troubleshoot as needed
- Utilize molecular biology techniques in performing laboratory tests
- Adhere to environmental, health and safety (EHS) guidelines and good laboratory practices (GLP)
- Perform other tasks as specified by the manager/director
Qualifications
- BS/BA in a biological science or equivalent
- Minimum of 2 years Molecular Biology laboratory experience required
Knowledge, Skills, and Abilities
- gDNA isolation from biological samples (preferred)
- Experience with library preparation for next generation sequencing and sequencing platforms
- Experience with hybrid capture technologies
- Experience with laboratory automated liquid handler platforms
- Sample analysis/QC on the Agilent Tapestation, Nanodrop, Qubit, electrophoresis
- Must have proven interpersonal, communication, computer, and technical skills
- Excellent oral and written communication skills required
- Microsoft Excel experience required
Requirements
- BS/BA in a biological science or equivalent
- Minimum of 2 years Molecular Biology laboratory experience required
- Experience with library preparation for next generation sequencing and sequencing platforms
- Experience with hybrid capture technologies
- Experience with laboratory automated liquid handler platforms
- Sample analysis/QC on the Agilent Tapestation, Nanodrop, Qubit, electrophoresis
- Must have proven interpersonal, communication, computer, and technical skills
- Excellent oral and written communication skills required
- Microsoft Excel experience required
- gDNA isolation from biological samples (preferred)
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
- Company Holidays
- Wellness Benefits
- Life Insurance
- Disability Plans
- Free Testing
- Fertility Care Benefits
- Pregnancy & Baby Bonding Leave
- Commuter Benefits
- Employee Referral Program
Company overview
Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in molecular diagnostics for oncology, women's health, and organ health. Founded in 2004 and headquartered in Austin, Texas, the company has developed a cutting-edge cfDNA technology platform that combines novel molecular biology techniques with bioinformatics software and artificial intelligence. Natera's proprietary technology enables detection down to a single molecule in a tube of blood, making it possible to provide highly accurate genetic testing services. The company's flagship products include Signatera, a personalized circulating tumor DNA test for cancer monitoring; Panorama, a non-invasive prenatal test for chromosomal abnormalities; and Prospera, a transplant rejection assessment test. With over 4,400 employees and operations in CLIA-certified, CAP-accredited laboratories in Austin and San Carlos, California, Natera has processed more than 12 million tests and validated its technology through over 300 peer-reviewed publications. The company went public in 2015 and continues to innovate in precision medicine, aiming to make personalized genetic testing part of standard healthcare to enable earlier interventions and improved patient outcomes.